Dissemination
GHD
SECONDARY, GHD
The GHD Reversal Trial protocol will be made publicly available via both the GHD Reversal Trial webpage hosted by the Trial Office and subsequently published in an appropriate journal, in advance of the final data set. Upon completion of the trial and analysis of the final dataset, a Final Report to the Funder will be prepared. The results of this trial will be submitted for publication in a peer reviewed journal. The manuscript will be prepared by the co-investigators and authorship will be determined by the BCTU trial publication policy. Any secondary publications and presentations prepared by Investigators must be reviewed and approved by the TMG prior to submission. Manuscripts must be submitted to the TMG in a timely fashion to allow time for review and resolution of any outstanding issues. Authors must acknowledge that the trial was performed with the support of BCTU/UoB, UCL, and JKU. The results of the trial will be disseminated by the trials unit to participating clinical centres, who will be asked to distribute this to the participants and the wider clinical community.